Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2003 Aug;89 Suppl 1(Suppl 1):S50-8.
doi: 10.1038/sj.bjc.6601084.

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

A Villers  1 , P Pommier, A Bataillard, B Fervers, J M Bachaud, N Berger, A F Bertrand, R Bouvier, D Brune, A Daver, E Fontaine, O Haillot, J L Lagrange, V Molinie, J P Muratet, P Pabot du Chatelard, M Peneau, D Prapotnich, V Ravery, P Richaud, D Rossi, M Soulie; FNCLCC; AFU
Affiliations
Guideline

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

A Villers et al. Br J Cancer. 2003 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Tumour stage according to method of detection.
Figure 2
Figure 2
Diagnostic investigation for patients with abnormal serum PSA concentration (T1c) and/or suspicious digital rectal examination or imaging studies (T2, T3,).
Figure 3
Figure 3
Management of patients with stage T1a and T1b tumours.
Figure 4
Figure 4
Staging for a histologically proven invasive cancer.
Figure 5
Figure 5
Therapeutic management of patients with stage T1 or T2 tumours.
Figure 6
Figure 6
Therapeutic management of patients with stage T3 tumours.
Figure 7
Figure 7
Therapeutic management of patients with stage N1 tumour (imaging studies).
Figure 8
Figure 8
Watch and wait policy.
Figure 9
Figure 9
Post-treatment follow-up.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Fervers B, Hardy J, Blanc-Vincent MP, Theobald S, Bataillard A, Farsi F, Gory G, Debuiche S, Guillo S, Renaud-Salis JL, Pinkerton R, Bey P, Philip T (2001) SOR: project methodology. Br J Cancer 84 (Suppl 2), 8–16 - PMC - PubMed
    1. Villers A, Pommier P, Bataillard A, Fervers B, Bachaud JM, Berger N, Bertrand AF, Bouvier R, Brune D, Daver A, Fontaine E, Haillot O, Lagrange JL, Molinié V, Muratet JP, Pabot du Chatelard P, Peneau M, Prapotnitch D, Ravery V, Richaud P, Rossi D, Soulié M (2002) Fédération Nationale des Centres de Lutte Centre le Cancer. (ed) Cancer de la prostate non metastatique (Non M, Vol. 14. Paris: John Libbey EUROTEXT; Standards Options & Recommendations

MeSH terms

Substances